Esthesioneuroblastoma, also known olfactory neuroblastoma.
Esthesioneuroblastoma is a rare cancer of the higher part of the nasal cavity. It develops in fabric of dependent nerve within the meaning of the odor and can occur in the people of any age. Esthesioneuroblastoma develops usually slowly but with the behavior locally aggressive. It draws aside by the planes submucosal with the surrounding structures and invades fall to it cranial former, destroying the dish of cribriform with the propagation along spaces perineural of the olfactive nerves. It assigns men and women also and occurs in all the categories of age.
The most common symptom of the esthesioneuroblastoma is chronic unilateral congestion. Other symptoms of esthesioneuroblastoma can include the nasal obstruction, the loss of odor, the chronic sinusitis and the nasal bleeding. The size and the extent of the diffusion of the tumour can moreover pose neurological symptoms, facial swelling, and oral and ophthalmic problems. The cause of ENB is sources discussed and proposed origin include the autonomous ganglia in the nasal mucosa, the ganglion of sphenopalatine, the olfactive placode ectodermal, and the olfactive epithelium, last being the site more envisaged origin.
Smokers are thought to be of the risk increased for ENB. The treatment of the esthesioneuroblastoma depends on the stage of tumour; the traditional strategies of treatment for ENB are surgery or radiotherapy or a combination from both. The radiotherapy and chemotherapy also play a significant part in the management of this tumour. The radiotherapy is used mainly postopératoirement when the microscopic positive margins are present or when the local repetition develops it would be too dangerous réséquer that. Chemotherapy proved to be useful, in particular for the order of the tumours metastatic or those considered to be unresectable.
